Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Entries Open For The Global Generics & Biosimilars Awards 2021

Awards Ceremony Will Take Place In Milan, Italy In November

Executive Summary

Entries are now open for the Global Generics & Biosimilars Awards 2021, which will take place in Milan, Italy on 10 November.

Entries are now open for Informa Pharma Intelligence’s Global Generics & Biosimilars Awards 2021, which will this year take place in Milan, Italy on 10 November.

The awards, now in their eighth year, celebrate successes across the generics, biosimilars, and value-added medicines industries. This year’s event – which is free to enter and free to attend via complimentary tickets – is accepting entries based on any activities undertaken between 1 July 2020 and 30 June 2021. The deadline for entries is 30 July.

“The Global Generics & Biosimilars Awards are always a highlight of the calendar and provide the perfect opportunity to recognize the off-patent sector’s greatest achievements over the past year,” said Generics Bulletin executive editor David Wallace. “At a time when people are appreciating the value of the pharmaceutical industry more than ever, this is the one night of the year when generics, biosimilars and value-added medicines companies and their industry partners can put their work centre stage.”

Categories crown the industry’s leading companies, both on a global and regional basis; highlight achievements in biosimilars and value-added medicines; and also recognize the industry’s biggest deals, business development initiatives, regulatory milestones and company leaders.

Active pharmaceutical ingredient suppliers and other industry partners also have their own categories in which to compete for recognition, while companies are also presented with awards for their CSR activities.

And this year our traditional legal strategy award has seen its scope expanded to cover all aspects of intellectual property strategy, not solely legal affairs.

“Whether you focus on generics, biosimilars or value added medicines, whether you are a small or a large company, and wherever you operate in the world, there is a category at the Global Generics & Biosimilars Awards to recognize your achievements,” Wallace commented. “I look forward to this year’s entries and to seeing the leading lights of the industry once again gather to celebrate their best and brightest in November.”

For a full list of awards categories, criteria and information about how to enter, go here.

To enquire about sponsorship opportunities for the Global Generics & Biosimilars Awards 2021, please e-mail

To register to attend the Global Generics & Biosimilars Awards 2021, to receive the latest updates and for any further details, please e-mail





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts